CinamatX is Storytelling for the Life Sciences Industry

 “The concept team identified the need to develop a signature video for our company that clearly described the unmet need, the underserved patient population, and positioned our novel therapy as the solution. The result was a fantastic 3-minute video that showcased LimFlow as the most exciting new therapy for Chronic Limb-Threatening Ischemia patients. Their team did an excellent job of drafting the script, integrating eye-catching visuals, and prepping our team for production. The team did an excellent job on our signature video and it’s the first thing anyone sees when they visit our website.”  John Weaver, Global Marketing Director, LimFlow

“Great from start to finish. I loved the creative storyline they came up with – which really captured the essence of our next-generation product, and why it is so important. The whole process from scriptwriting, filming and editing was all really professional. I’m delighted with the final piece.” John Von Benecke, CEO, LocateBio

“Beyond the top-notch work product and the professionalism, something that stood out to me was the team's ability to recognize when something isn’t going to plan or working, have the agility to change course, and create something different, and in my case, probably better than the original vision.” Bradley Beach, CEO, Covellus Medical

Epic Sciences, DefineMBC evaluates key biomarkers to help establish comprehensive care plans for patients with metastatic breast cancer. The analysis is a minimally invasive blood sample that provides comprehensive clinical data that includes Cell-based analysis of ER and HER2 protein expression Single-Cell Genomic Analysis for ERBB2 amplification and genomic instability and ctDNA evaluation of MSI, TMB, and genomic alterations in 56 relevant genes.  Visit Epic Sciences.

“Kristy and team are really great!  We did some work together a few years ago and I was impressed.  Certainly, I will be looking for ways to work with her and her team again.”

Dr. Josh Makower is the Boston Scientific Applied Bioengineering Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering and the Director of the Stanford Byers Center for Biodesign. He also is the Founder & Executive Chairman of ExploraMed, a medical device incubator, creating 9 companies since 1995. Transactions from the ExploraMed portfolio include NeoTract, acquired by Teleflex, Acclarent, acquired by J&J, EndoMatrix, acquired by C.R. Bard & TransVascular, acquired by Medtronic. Other ExploraMed/NEA ventures include Moximed, NC8 and Willow. Josh is also a Special Partner at NEA where he supports the healthcare team and medtech/healthtech investing practice.

"I have known Kristy for years.  She is highly committed to the success of the life sciences industry with a keen eye on truly breakthrough innovation for the benefit of patients.  Her energy is infectious and I have always enjoyed collaborating with her. "   

Renee Ryan has 25 years of building category-creating healthcare companies. She led the medical technology investments for Johnson & Johnson Innovation (JJDC) on the West Coast and Asia Pacific for 8 years. While at J&J, she made over 15 new investments, including the Series A for Cala Health. Previously, she was a healthcare investment banker at RW Baird, Jefferies and Goldman Sachs.

"I have known Kristy Kennedy for two decades over which time she has developed a deep understanding of the value medical technology provides in our healthcare system. Through that knowledge base she has developed CinamatX, a unique presentation of Medtech companies through creative video experience. Kristy has adeptly captured key value points for each of the stakeholders in messaging the company, not merely presenting a technology. Clinicians, providers, payers and patients alike will all take notice as these dramatizations will likely be their first encounter with the respective companies."

’I’ve worked with Kristy Kennedy for many years.  Her connections and willingness to help connect medtech startups with investors and strategics is truly unique. She has made many impactful connections for us over the years as well as providing us guidance on best communication strategies.  Having engaging video content for any startup is essential, but applying your company’s branding and messaging in the right way can prove difficult if you aren’t working with the right people who might not understand our industry and community. Kristy strikes a perfect balance in her approach to creating content."

Berk Tas serves as the Chief Executive Officer and President of SentiAR. Berk has led the development of emerging technologies and companies in Fortune 500, private equity, venture capital funded, and privately held organizations. Prior to joining SentiAR he led the development of a novel Trans-aortic Valve Replacement technology into CE Mark studies at HLT Medical. In 2016, he played an integral role in the acquisition of Sensium, Oxford UK, a novel wireless monitoring technology. 

’"Kristy is a longtime friend of HealthTech Innovation and one of a few people that make me WANT to go to conferences just to see her.  Her enthusiasm and generous example remind me of WHY I began working in healthcare innovation.  Healthcare is both a very complex industry but one where the potential to “do well by doing good” is off the charts!  There are many many great people with incredible vision for game changing ideas … who need friends, scouts, and collaborators to make their ideas reality.  If you have spent any time at all around Kristy, you will immediately realize she is all of these things and more to countless entrepreneurs and innovators of all shapes and sizes along the spectrum of innovation.  I believe that her natural compassion coupled with an uncanny ability to draw out stories and the very best in others will make anyone who trusts their “visual storytelling” to her and TEAM CinamatX will be very happy that they did.”  

Benjamin Glenn is a partner at Shay Glenn LLP, where he specializes in strategic patents and innovations counseling. Benjamin’s litigation, patent prosecution and strategic counseling experience in a range of technologies allow him to assist clients in establishing and protecting valuable intellectual property portfolios. Benjamin primarily advises venture-backed companies and investors in intellectual property matters arising during investment rounds, corporate formation, and throughout a company’s product development cycle with an emphasis in companies within the medical device industry.

"I’ve always been impressed with Kristy Kennedy from our first meeting and working with her on various projects for over 15 years.  Her relationships, knowledge, and network within the life sciences community are more than impressive and our shared drive for innovation and connecting companies to the right stakeholders has been a highlight.  Now more than ever there is a need for life science companies to think differently about their company awareness strategies and video is one of the most important tools to actively entice investors and strategics.  You must collaborate with partners that understand your technology but also can devise a streamlined concept using the knowledge they have acquired for years in our industry.

Kristy will get the job done. Guaranteed."

Carla Kikken-Jussen founded MediTech in 2000 and has worked in the medical device industry for more than 30 years. In 2012 MediTech merged with Medpace Medical Device, US to form a comprehensive global development group, conducting clinical research and regulatory affairs consultation for global medical device studies. 

Carla has served on the board of the Life Sciences Limburg Group and is a member of the Dutch Standardization Institute (NEN), the Regulatory Affairs Professional Society (RAPS) European Advisory Committee, the Orange County Regulatory Affairs organization, and Member of the Board of Certification for CMDA (Certified Medical Device Associate) clinical evaluation.